Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 04 Sep 2024

Insights from pharmacovigilance and pharmacodynamics on cardiovascular safety signals of NSAIDs

in Pharmacoepidemiology

Shuang Liang
Xianying Wang
Xiuqing Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455212

2,808 views
1 citation

Original Research

Published on 04 Sep 2024

A discovery and verification approach to pharmacovigilance using electronic healthcare data

in Pharmacoepidemiology

Louis Dijkstra
Tania Schink
Roland Linder
Markus Schwaninger
Iris Pigeot
Marvin N. Wright
Ronja Foraita

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426323

1,360 views
1 citation

Original Research

Published on 29 Aug 2024

Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study

in Pharmacoepidemiology

Kai Du
Ao Li
Chen-Yu Zhang
Shu-Ming Li
Ping Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448319

2,837 views

Systematic Review

Published on 23 Aug 2024

Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis

in Pharmacoepidemiology

Xiaoqi Li
Qiaozhi Hu
Ting Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368274

1,619 views
2 citations

Original Research

Published on 22 Aug 2024

Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity

in Pharmacoepidemiology

Yimou Liu
Qian Chen
Tianyang Hu
Changming Deng
Jing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428210

2,215 views
3 citations

Editorial

Published on 20 Aug 2024

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies

in Pharmacoepidemiology

Zakir Khan
Yusuf Karatas
Ahmet Akici
Maria Auxiliadora Parreiras Martins
Nafees Ahmad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1473052

1,780 views

Original Research

Published on 13 Aug 2024

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system

in Pharmacoepidemiology

Yiwen Wang
Xuna Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392263

1,929 views
2 citations

Original Research

Published on 13 Aug 2024

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Lu Wang
Shipeng Zhang
Hengxu Liu
Hongping Wang
Tao Liu
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432759

4,094 views
4 citations

Systematic Review

Published on 31 Jul 2024

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis

in Pharmacoepidemiology

Huifang Zhang
Yang Liu
Xiyu Shang
Yuqing Cao
Jiajia Li
Guangkun Chen
Xinyu Ji
Lei Zhang
Yipin Fan
Yan Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422773

1,604 views
1 citation

Original Research

Published on 31 Jul 2024

The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

in Pharmacoepidemiology

Jungmi Chae
Ho Jin Cho
Sang-Heon Yoon
Dong-Sook Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382990

1,950 views
1 citation

Original Research

Published on 26 Jul 2024

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacoepidemiology

Yanli Qiao
Yechao Chen
Qiaoyun Wang
Jingrui Liu
Xiaohui Guo
Qiaoling Gu
Peng Ding
Haixia Zhang
Hongliang Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413944

4,855 views
1 citation

Original Research

Published on 24 Jul 2024

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database

in Pharmacoepidemiology

Michael Magdy Fahmy Girgis
Gergely Farkasinszky
Klára Fekete
István Fekete
Miklós Vecsernyés
Ildikó Bácskay
László Horváth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411134

1,910 views
1 citation

Review

Published on 24 Jul 2024

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

in Pharmacoepidemiology

Zhen Zeng
Hao Lin
Mingshan Jiang
Jing Yuan
Xi Li
Yongbin Jia
Li Yang
Hu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424606

3,107 views
3 citations

Original Research

Published on 24 Jul 2024

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system

in Pharmacoepidemiology

Liangxia Li
Qianqian Xu
Yarui Liu
Liangfang Pang
Zhou Cui
Yuanyuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403988

2,304 views
1 citation

Original Research

Published on 22 Jul 2024

Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China

in Pharmacoepidemiology

Nan Shang
Xianlin Li
Zhiyu Guo
Lan Zhang
Shanshan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362345

1,337 views
1 citation

Original Research

Published on 19 Jul 2024

Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis

in Pharmacoepidemiology

Yin Li
Yu Xiong
Wenxin Fan
Kai Wang
Qingqing Yu
Liping Si
Patrick van der Smagt
Jun Tang
Nutan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371504

1,382 views
1 citation